MELANOCORTIN TYPE 2 RECEPTOR (MC2R) TARGETED THERAPEUTICS AND USES THEREOF

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20230405157A1
SERIAL NO

18313915

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Described herein are radiotherapeutics that target tumor cells expressing the melanocortin type 2 receptor (MC2R) and their use in the treatment and/or diagnosis of cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RADIONETICS ONCOLOGY INC70 WILLOW ROAD SUITE 200 MENLO PARK CA 94025

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
CHEN, Mi San Diego, US 54 492
KIM, Sun Hee San Diego, US 69 651
ZHAO, Jian San Diego, US 422 5285
ZHU, Yunfei San Diego, US 44 125

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation